AcuNetx Unveils Advanced Prototype HawkEye(TM) System to Acclaim from National Law Enforcement Experts.

Evidence Capture Device Enables Infrared Video Recording and Playback of Telltale Eye Signs from DUI and Drug Abuse Suspects

SUPERIOR, Colo. -- AcuNetx (OTCBB:ANTX) last month unveiled its advanced, patent-pending HawkEye[TM] infrared video capture device to the national law enforcement community in two separate venues: the Governors Highway Safety Association meeting in Oklahoma City, and the invitation-only Advisory Council meeting of the government's Office of Law Enforcement Technology Commercialization (OLETC, www.oletc.org) meeting in Charleston, S.C.

HawkEye is the newest entrant into AcuNetx' law enforcement and correctional product line, which is manufactured and marketed by the Company's VisioNetx division. HawkEye enables police officers and Drug Recognition Experts to capture, for the first time, objective evidence of a suspect's eye movements regardless of lighting conditions for use as evidence in prosecuting DUI suspects and drug users. Trained officers customarily make note of eye signs of suspects using long-established Standardized Field Sobriety Test and Drug Recognition Expert protocols, but until HawkEye, had no objective, archived means of capturing the eye signs for others to see and evaluate.

An early evaluator of the HawkEye prototype, Professor of Optometry Karl Citek at Pacific University and a trainer and consultant to law enforcement agencies nationwide, commented: "This (HawkEye) is fantastic: light, portable, and, most importantly, it provides a full field of view horizontally and in up-gaze. The fact that I can see both eyes - and that (others) can see EXACTLY what I'm seeing - is tremendous!"

"HawkEye is an extension of our established medical technology that uses infrared video eye tracking to diagnose dizziness and vertigo," said Ron Waldorf, AcuNetx' Vice President of Innovation and Product Development and the co-inventor of HawkEye. "This technology has the potential to vastly reduce costs associated with the identification and prosecution of impaired drivers and drug abusers." Waldorf was an invited presenter of the technology to OLETC. OLETC conducts an active, broad-based national program to assist in the commercialization of innovative technology for use by the law enforcement and corrections community, and is a program of the National Institute of Justice.

HawkEye also debuted at the Governors Highway Safety Association meeting, where Sgt. Richard Studdard (L.A.P.D. retired), founder of the now internationally adopted DRE program, commented: "HawkEye seems bound to achieve widespread adoption throughout the law enforcement community. It can serve as a training aid for police as well as an evidence capture device that substantially aids those of us who have spent our lives trying to rid the highways of drunk and impaired drivers."

"With such overwhelming acceptance of our prototype HawkEye by the law enforcement community, we look forward to full commercialization of the finished product in early 2007," said Terry Knapp, MD, CEO of AcuNetx.

For more information on HawkEye, visit www.visionetx.com.

About AcuNetx, Inc.

AcuNetx combines diagnostic, analytical and therapeutic devices with proprietary software to permit: health providers to diagnose and treat balance disorders and various bone deficiencies, law enforcement officers to evaluate roadside sobriety, and employers in high-risk industries to determine Co in real-time Co the mental fitness of their employees to perform mission-critical tasks. AcuNetx is headquartered in Superior, and has operating divisions in Torrance, Calif. For more information about AcuNetx and its divisions, please visit www.acunetx.com.

Safe Harbor for Forward-Looking Statements

This news release contains "forward-looking statements" that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. While these statements are made to convey to the public the company's progress, business opportunities and growth prospects, readers are cautioned that such forward-looking statements represent management's opinion. Whereas management believes such representations to be true and accurate based on information and data available to the company at this time, actual results may differ materially from those described. The company's operations and business prospects are always subject to risk and uncertainties. Important factors that may cause actual results to differ are set forth in the company's periodic filings with the U.S. Securities and Exchange Commission.